[Hypertrophic cardiomyopathies and ATTR amyloidosis - a current review for clinical practice]. / Hypertrophe Kardiomyopathien und die kardiale ATTR-Amyloidose eine aktuelle Übersicht für den klinischen Alltag.
Dtsch Med Wochenschr
; 147(17): 1127-1134, 2022 09.
Article
em De
| MEDLINE
| ID: mdl-36030786
Cardiomyopathies include dilated and restrictive cardiomyopathies as well as the various forms of hypertrophic cardiomyopathies (HCM). By definition, HCM is considered to occur when left ventricular wall thickness is ≥â15âmm. This may be masked by genetic sarcomeric diseases, storage diseases, or syndromes. In clinical practice, sarcomere mutations and the cardiac amyloidoses are of particular interest because they are not always easy to distinguish from each other and early diagnosis of the disease is important for prognosis.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Cardiomiopatia Hipertrófica
/
Amiloidose
/
Cardiomiopatias
Tipo de estudo:
Screening_studies
Limite:
Humans
Idioma:
De
Revista:
Dtsch Med Wochenschr
Ano de publicação:
2022
Tipo de documento:
Article